MX2020005777A - Composicion basada en probioticos y uso de la misma. - Google Patents
Composicion basada en probioticos y uso de la misma.Info
- Publication number
- MX2020005777A MX2020005777A MX2020005777A MX2020005777A MX2020005777A MX 2020005777 A MX2020005777 A MX 2020005777A MX 2020005777 A MX2020005777 A MX 2020005777A MX 2020005777 A MX2020005777 A MX 2020005777A MX 2020005777 A MX2020005777 A MX 2020005777A
- Authority
- MX
- Mexico
- Prior art keywords
- probiotics
- composition
- disorders
- preventing
- composition based
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/001—Preparations for care of the lips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
Abstract
La presente invención se refiere a una composición que comprende probióticos, de preferencia basados en bacterias, en particular del género Lactobacillus, para ser utilizada para el propósito de prevenir y/o tratar los trastornos que afectan la piel, en particular trastornos inflamatorios, en particular trastornos autoinflamatorios de interés dermatológico tal como dermatitis atópica. Asimismo, la composición de la invención es útil para prevenir y/o reducir el daño inducido por radiación UV, en particular envejecimiento de la piel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT201700141330 | 2017-12-06 | ||
PCT/IB2018/059694 WO2019111189A1 (en) | 2017-12-06 | 2018-12-06 | Composition based on probiotics and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020005777A true MX2020005777A (es) | 2020-11-06 |
Family
ID=61656196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020005777A MX2020005777A (es) | 2017-12-06 | 2018-12-06 | Composicion basada en probioticos y uso de la misma. |
Country Status (12)
Country | Link |
---|---|
US (2) | US11534468B2 (es) |
EP (1) | EP3720457A1 (es) |
JP (2) | JP2021505689A (es) |
KR (1) | KR20200096807A (es) |
CN (1) | CN111511379A (es) |
AU (1) | AU2018378419A1 (es) |
BR (1) | BR112020010930A2 (es) |
CA (1) | CA3084735A1 (es) |
EA (1) | EA202091389A1 (es) |
MX (1) | MX2020005777A (es) |
WO (1) | WO2019111189A1 (es) |
ZA (1) | ZA202003788B (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20131467A1 (it) | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
MA45288A (fr) | 2016-06-08 | 2019-04-17 | Sofar Spa | Nouvelle utilisation médicale de probiotiques |
IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
EP3979982B1 (en) * | 2019-06-05 | 2023-04-05 | Lac2Biome S.R.L. | Compositions comprising a bacterial strain lactobacillus paracasei and hyaluronic acid and the use thereof for the treatment of the skin |
IT201900016865A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Composizioni a base di ceppi batterici e loro uso come antinfiammatori |
IT201900016850A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Composizioni a base di ceppi batterici e estratti di bacche e loro uso come antinfiammatori |
US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
KR102167387B1 (ko) | 2020-05-14 | 2020-10-19 | 코스맥스 주식회사 | 피부 장벽 강화, 피부 보습 또는 항노화를 위한 조성물 |
GB2598548B (en) * | 2020-08-21 | 2023-12-27 | Iiaa Ltd | Composition for improving the microbiome |
US11517597B2 (en) * | 2020-09-29 | 2022-12-06 | Chambio Co., Ltd. | Method for improving skin condition with postbiotic extract |
CN112094784B (zh) * | 2020-09-30 | 2022-04-15 | 江南大学 | 一株能够抑制HaCaT细胞异常增殖的副干酪乳杆菌 |
WO2022077276A1 (zh) * | 2020-10-14 | 2022-04-21 | 音芙医药科技(上海)有限公司 | 烟酰胺单核苷酸与发酵乳杆菌联合在制备缓解皮肤光老化制剂中的应用 |
KR102244492B1 (ko) * | 2020-10-21 | 2021-04-26 | 대한민국(관리부서:국립수산과학원) | 신규 락토바실러스 속 균주 및 그의 용도 |
FR3117340B1 (fr) | 2020-12-15 | 2024-01-05 | Basf Beauty Care Solutions France Sas | Utilisation cosmétique, nutraceutique ou dermatologique d’une souche deLactobacillus crispatus et / ou d’une composition la comprenant |
CN112546074B (zh) * | 2020-12-24 | 2022-09-27 | 江南大学 | 一株能够抑制IL-23、Th17轴相关炎症因子释放的短双歧杆菌及其应用 |
CN112852902B (zh) * | 2021-01-19 | 2022-09-16 | 南昌大学 | 一种具有免疫调节作用的肠球菌胞外多糖及其制备方法和应用 |
CN112915110B (zh) * | 2021-03-01 | 2022-12-09 | 北京亿康倍尔生物科技有限公司 | 一种纤体养颜益生菌制剂及其制备方法与应用 |
AU2022232944A1 (en) * | 2021-03-12 | 2023-10-05 | MarvelBiome, Inc. | Methods and uses of microbiome compositions, components, or metabolites for treating eye disorders |
CN112754988B (zh) * | 2021-03-22 | 2022-06-28 | 中南大学湘雅二医院 | 一种降低皮肤致敏性的益生菌护肤品及其制备方法 |
CN112940996B (zh) * | 2021-05-06 | 2022-04-19 | 君维安(武汉)生命科技有限公司 | 一种调控表皮微生态平衡的益生菌、其产品及应用 |
WO2022245875A1 (en) * | 2021-05-17 | 2022-11-24 | Viome Life Sciences, Inc. | Supplements for supporting mental health |
IT202100017855A1 (it) * | 2021-07-06 | 2023-01-06 | Lac2Biome S R L | Bacteria strains for topical skin care |
CN113576943B (zh) * | 2021-07-09 | 2022-07-12 | 中山大学 | 一种益生元发酵物及其制备方法与应用 |
CN113832050B (zh) * | 2021-08-13 | 2022-10-21 | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 一株高效合成烟酰胺、抗光老化的发酵乳杆菌xjc60及其应用 |
KR102411241B1 (ko) * | 2021-10-18 | 2022-06-22 | 큐티스바이오 주식회사 | 코리네박테리움 상귀니스의 피부 상태 개선 용도 |
CN114558037B (zh) * | 2022-02-24 | 2023-08-15 | 同济大学 | Akk和ls在制备提高认识水平的抗衰老产品中的应用 |
FR3134010A1 (fr) | 2022-03-30 | 2023-10-06 | Basf Beauty Care Solutions France Sas | Utilisation cosmétique, nutraceutique et/ou dermatologique d’une souche de Lactobacillus crispatus et/ou d’une composition la comprenant |
KR102609655B1 (ko) * | 2022-07-27 | 2023-12-06 | 코스맥스 주식회사 | 스트렙토코커스 소브리너스 균주 및 그의 피부 상태 개선 용도 |
CN115364124A (zh) * | 2022-06-10 | 2022-11-22 | 内蒙古伊利实业集团股份有限公司 | 一种防治口腔溃疡的益生菌贴剂及其制备方法与应用 |
CN114806977B (zh) * | 2022-06-21 | 2022-10-21 | 山东锦鲤生物工程有限公司 | 一株唾液乳杆菌及其在制备抗皮炎的产品中的应用 |
CN115181699B (zh) * | 2022-06-28 | 2023-08-29 | 广东粤港澳大湾区国家纳米科技创新研究院 | 一株长双歧杆菌cb20y1及其应用 |
CN115181698B (zh) * | 2022-06-28 | 2023-09-08 | 广东粤港澳大湾区国家纳米科技创新研究院 | 一种益生菌组合物及应用 |
KR102491324B1 (ko) * | 2022-07-05 | 2023-01-26 | 일동바이오사이언스(주) | 락티카제이바실루스 람노서스 idcc 3201의 발효를 이용한 콜라겐의 저분자화 방법과 콜라겐 및 포스트바이오틱스가 혼합된 복합체 |
CN115044519B (zh) * | 2022-08-12 | 2022-10-25 | 山东锦鲤生物工程有限公司 | 解淀粉乳杆菌及其应用 |
CN116064330B (zh) * | 2023-01-10 | 2024-05-03 | 北京工商大学 | 凝结芽孢杆菌及其应用 |
CN116376758A (zh) * | 2023-03-15 | 2023-07-04 | 广东南芯医疗科技有限公司 | 詹氏乳杆菌ls06及其在制备治疗或预防过敏性疾病药物中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020044926A1 (en) * | 1999-12-10 | 2002-04-18 | Gregor Reid | Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
PT1322318E (pt) * | 2000-10-06 | 2011-03-15 | Oreal | Utilização de bactérias ácido lácticas probióticas para prevenção de reacções inflamatórias ou alérgicas ou imunossupressão induzidas por radiações ultravioleta na pele |
AU2003210311C1 (en) * | 2002-02-21 | 2009-04-02 | Societe Des Produits Nestle S.A. | Pet food composition for skin photoprotection |
FR2938437B1 (fr) * | 2008-11-19 | 2020-03-27 | Société des Produits Nestlé S.A. | Utilisation cosmetique de microorganisme pour le traitement des peaux grasses |
FR2942719B1 (fr) * | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
US8753624B2 (en) * | 2011-10-14 | 2014-06-17 | Genmont Biotech Incorporation | Composition and use of Lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases |
EP2581461B1 (en) * | 2011-10-14 | 2014-09-24 | GenMont Biotech Incorporation | Composition and use of lactobacillus paracasei strain GMNL-133 in treating atopic dermatitis or other allergic diseases |
ITMI20131467A1 (it) * | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
MA39710A (fr) * | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
KR20180056775A (ko) * | 2015-10-07 | 2018-05-29 | 갈데르마 리써어치 앤드 디벨로프먼트 | 유산균 함유 조성물 및 아토피 피부염을 치료하기 위한 이의 용도 |
-
2018
- 2018-12-06 WO PCT/IB2018/059694 patent/WO2019111189A1/en unknown
- 2018-12-06 CN CN201880078563.9A patent/CN111511379A/zh active Pending
- 2018-12-06 EA EA202091389A patent/EA202091389A1/ru unknown
- 2018-12-06 AU AU2018378419A patent/AU2018378419A1/en active Pending
- 2018-12-06 BR BR112020010930-4A patent/BR112020010930A2/pt unknown
- 2018-12-06 EP EP18830307.7A patent/EP3720457A1/en active Pending
- 2018-12-06 KR KR1020207019346A patent/KR20200096807A/ko active Search and Examination
- 2018-12-06 JP JP2020550940A patent/JP2021505689A/ja active Pending
- 2018-12-06 MX MX2020005777A patent/MX2020005777A/es unknown
- 2018-12-06 CA CA3084735A patent/CA3084735A1/en active Pending
- 2018-12-06 US US16/770,011 patent/US11534468B2/en active Active
-
2020
- 2020-06-22 ZA ZA2020/03788A patent/ZA202003788B/en unknown
-
2022
- 2022-11-23 US US17/993,782 patent/US20230093060A1/en active Pending
-
2023
- 2023-08-01 JP JP2023125494A patent/JP2023133467A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20200096807A (ko) | 2020-08-13 |
US20230093060A1 (en) | 2023-03-23 |
EP3720457A1 (en) | 2020-10-14 |
JP2021505689A (ja) | 2021-02-18 |
BR112020010930A2 (pt) | 2020-11-17 |
EA202091389A1 (ru) | 2020-09-11 |
US11534468B2 (en) | 2022-12-27 |
JP2023133467A (ja) | 2023-09-22 |
US20210236566A1 (en) | 2021-08-05 |
CA3084735A1 (en) | 2019-06-13 |
WO2019111189A1 (en) | 2019-06-13 |
ZA202003788B (en) | 2021-06-30 |
AU2018378419A1 (en) | 2020-07-09 |
CN111511379A (zh) | 2020-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020005777A (es) | Composicion basada en probioticos y uso de la misma. | |
MX2018011249A (es) | Composiciones topicas no acuosas que comprenden una salicilanilida halogenada. | |
PH12016501512B1 (en) | Treatment for resistant acne | |
BR112021025676A2 (pt) | Composições e métodos para tratar uma afecção mediada por th2 com o uso de prevotella | |
NZ757213A (en) | Compositions of plinabulin and use thereof | |
MY166552A (en) | Infant cereal comprising non-replicating probiotic microorganisms | |
MX2018000870A (es) | Metodos y materiales para mejorar las respuestas inmunitarias y funciones de la barrera de piel y/o mucosa. | |
DOP2016000006A (es) | Bencil-1h-pirazolo[3,4-b]piridinas y su uso | |
ZA201804863B (en) | Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation | |
FI20115135L (fi) | Mikrofibrilloitu selluloosa käytettäväksi erityisesti atooppisen ihotulehduksen ja psoriasiksen hoidossa | |
MX2022015456A (es) | Composiciones de maca y metodos de uso. | |
MX352736B (es) | Metodos y composiciones para mejorar la calidad del cabello mediante el uso de extracto de zarzamora. | |
MY188028A (en) | Sialylated glycoprotein compositions and uses thereof | |
MX2021011999A (es) | Sulfato de dextrano para afecciones inflamatorias de la piel. | |
MX2020002147A (es) | Composiciones útiles para la mejora del dolor. | |
EP3513799A4 (en) | COMPOSITION WITH LACTIC ACID BACTERIUM AS AN ACTIVE SUBSTANCE TO PREVENT OR REDUCE SKIN CONDITION THAT IS CAUSED BY THE ABNORMAL PROLIFERATION OF A SPECIFIC BACTERIUM IN THE SKIN | |
WO2017142368A3 (ko) | 알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물 | |
WO2015044318A3 (en) | Bacteria of the stenotrophomonas genus and/or growth inducer of said bacteria for preventing and/or treating atopic dermatitis | |
EP3282849A4 (en) | COMPOSITION AND METHODS FOR CONTROLLING THE GROWTH OF PATHOGENS AND DECOMPOSITION MICROORGANISMS IN SYSTEMS HAVING HIGH HUMIDITY AND LOW SODIUM CONTENT | |
WO2014158685A3 (en) | Tetracera asiatica extracts and methods of use | |
MX2020001501A (es) | Streptococcus australis como bioterapeuticos. | |
MX2018005083A (es) | Métodos para el tratamiento de acné comun mediante el uso de composiciones tópicas de dapsona. | |
IL276524A (en) | Nemolizumab for the treatment of atopic dermatitis with moderate to severe itching | |
CO2020009424A2 (es) | Composición que comprende nuevas cepas de lactobacillus salivarius y método para la prevención y el tratamiento de otitis e infecciones respiratorias de vías altas | |
WO2014148932A3 (en) | Use of plant aspartic proteases for treating skin conditions |